This inventor holds 1 USPTO granted patent. Top assignee: Akzo Nobel N.v.. Active years: 1998.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1998
Title: Franciscus M. Kaspersen and Targeted Therapeutic Delivery.
Introduction
Franciscus M. Kaspersen is an inventor associated with Heesch, the Netherlands, and Akzo Nobel N.V. His work includes a patent concerning targeted delivery of therapeutic entities.
Latest Patents
Kaspersen is credited with 1 patent: “Targeted Delivery of a Therapeutic Entity Using Complementary.” The invention describes labelled, modified oligonucleotides for antisense therapy and a conjugate combining a targeting moiety, such as an antibody, with a modified oligonucleotide complementary to the labelled oligonucleotide. The disclosed combination is intended for potential therapeutic use against viral infections, tumours, and autoimmune diseases. The patent also describes pharmaceutical formulations containing the compounds.
Career Highlights
Kaspersen’s listed patent work connects molecular targeting and modified oligonucleotides with therapeutic applications. The patent identifies Akzo Nobel N.V. as the company associated with his work.
Collaborations
The patent lists Wilhelmus H. Kuijpers and Constant A. Van Boeckel among Kaspersen’s coworkers.
Conclusion
Franciscus M. Kaspersen’s recorded invention focuses on combining targeted delivery with modified oligonucleotides for potential therapeutic applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile